{
    "title": "AstraZeneca signs billion-dollar deal with Japanese pharmaceutical giant to develop and sell cancer drugs",
    "url": "https://www.dailymail.co.uk/money/markets/article-8563845/AstraZeneca-signs-6bn-deal-develop-cancer-drugs.html",
    "date": "2020-07-27",
    "keywords": [
        "vaccine",
        "treatment",
        "cancer",
        "breast",
        "share",
        "astrazeneca",
        "company",
        "drug",
        "lung",
        "ds1062",
        "executive",
        "oncology",
        "world",
        "leadership",
        "trial",
        "fund",
        "market",
        "firm",
        "year",
        "daiichi",
        "development",
        "collaboration",
        "record",
        "coronavirus",
        "pandemic",
        "enhertu",
        "soriot",
        "value",
        "protein",
        "chemotherapy",
        "medicine",
        "vice",
        "president",
        "covid19",
        "work",
        "cent",
        "dose",
        "investment",
        "account",
        "fee",
        "upfront",
        "tumours",
        "cancersanother",
        "dependent",
        "therapy",
        "reliant",
        "enhertuastrazeneca",
        "commercialisation",
        "japan",
        "rightsdaiichi",
        "sunao",
        "manabe",
        "bestinclass",
        "cancershe",
        "experience",
        "expertise",
        "business",
        "footsie",
        "article",
        "agreement",
        "sankyo",
        "launch",
        "pipeline",
        "soriothe",
        "astrazenecas",
        "trop2",
        "cancershoning",
        "body",
        "procedurethe",
        "use",
        "country",
        "safety",
        "efficacy",
        "week",
        "price",
        "high",
        "ftse",
        "capitalisationthis",
        "tagrisso",
        "imfinzi",
        "companys",
        "rival",
        "glaxosmithklineastrazeneca",
        "union",
        "cell",
        "calquence",
        "leukaemia",
        "forefront",
        "oxford",
        "university",
        "mene",
        "lancet",
        "tcell",
        "response",
        "virus",
        "number",
        "research",
        "data",
        "confidence",
        "scale"
    ],
    "category": [
        "money",
        "markets"
    ]
}